Skip to main content
Literatur
7.
Zurück zum Zitat Hillner BE, Siegel BA, Shields AF, et al. The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry. Cancer. 2009;115:410–8. CrossRef Hillner BE, Siegel BA, Shields AF, et al. The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET Registry. Cancer. 2009;115:410–8. CrossRef
15.
Zurück zum Zitat Roop MJ, Singh B, Singh H, et al. Incremental value of cocktail 18F-FDG and 18F-NaF PET/CT over 18F-FDG PET/CT alone for characterization of skeletal metastases in breast cancer. Clin Nucl Med. 2017;42:335–40. CrossRef Roop MJ, Singh B, Singh H, et al. Incremental value of cocktail 18F-FDG and 18F-NaF PET/CT over 18F-FDG PET/CT alone for characterization of skeletal metastases in breast cancer. Clin Nucl Med. 2017;42:335–40. CrossRef
Metadaten
Titel
Total-body pediatric PET is ready for prime time
verfasst von
Mehdi Djekidel
Rahaf AlSadi
Maya Abi Akl
Stefaan Vandenberghe
Othmane Bouhali
Publikationsdatum
20.06.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2022
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-05873-y

Weitere Artikel der Ausgabe 11/2022

European Journal of Nuclear Medicine and Molecular Imaging 11/2022 Zur Ausgabe